Candidiasis: Clinical Trials

35 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 4 terminated, 2 unknown, 1 not yet recruiting. 35 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 435Completed 26, Terminated 4, Unknown 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial
Caspofungin only within the study, Caspofungin for 3 days within the study, Placebo only within the study - Candidemia, Invasive Candidiasis
Phase 4Not yet recruitingOliver Cornely, MD4202026-09-012026-09-01
Evaluate Bioequivalence of Micafungin (50mg/Vial)
Micafungin - Invasive Candidiasis
Phase 4CompletedYung Shin Pharm. Ind. Co., Ltd.142022-01-062022-08-11
Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons
Miconazole, CandBerrol® lozenges - Oral Candidiases
Phase 4UnknownUniversity of Belgrade902021-05-012023-06-23
Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis
Fluconazole, L-Mesitran - Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina
Phase 4UnknownMaastricht University Medical Center2522021-03-012020-11-12
Study of Lactobacillus in Adjuvant Treatment of RVVC
clotrimazole vaginal tablets, Clotrimazole vaginal tablets+ Lactobacillus - Recurrent Vulvovaginal Candidiasis
Phase 4CompletedPeking University Shenzhen Hospital1402020-07-012025-06-12
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration
Fluconazole 200mg tab, Fluconazole 2 MG/ML - Fluconazole, Candidiasis
Phase 4CompletedRadboud University Medical Center252019-11-302021-07-14
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
Posaconazole pharmacokinetics - Posaconazole, Pharmacokinetics
Phase 4RecruitingMelbourne Health1002019-08-012025-02-28
Evaluation of Efficacy and Safety of Gynomax® XL Ovule
Gynomax® XL Vaginal Ovule - Trichomonal Vaginitis, Bacterial Vaginosis
Phase 4CompletedExeltis Turkey1162019-04-032020-01-31
Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin
1,3-β-D-glucan quantification, Micafungin - Invasive Candidiasis
Phase 4TerminatedFadoi Foundation, Italy142018-07-182021-04-12
Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
Boric acid and probiotics, Antibiotic (Clindamycin), Antifungal (Clotrimazole) - Candidiasis, Vaginosis, Bacterial
Phase 4CompletedLaboratorios Ordesa482016-07-122019-11-19
Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis
Fluomizin vaginal tablets, Canesten vaginal tablets - Vulvovaginal Candidiasis
Phase 4CompletedMedinova AG1502014-11-012016-09-15
Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis
Clotrimazole vaginal tablet, Fluconazole - Candidiasis, Vulvovaginal
Phase 4CompletedPeking University Shenzhen Hospital2402014-07-012017-05-02
Pharmacokinetics of Micafungin in Patients of Intensive Care Units
micafungin - Invasive Candidiasis
Phase 4CompletedUniversity Hospital, Limoges602014-06-012025-11-21
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
Micafungin - Aspergillosis, Candidiasis
Phase 4TerminatedAstellas Pharma China, Inc.1052014-03-212024-11-07
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
Micafungin - Candidemia, Candidiasis
Phase 4TerminatedAstellas Pharma China, Inc.592013-09-262024-11-20
Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis
Terconazole Vaginal Suppository, Fluconazole - Vulvovaginal Candidiasis
Phase 4CompletedPeking University Shenzhen Hospital1402013-08-012020-10-23
Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis
Clotrimazole - Candidiasis, Vulvovaginal
Phase 4CompletedInstituto Palacios562013-06-012015-03-25
Negative Beta Glucan in ICU Patients
Anidulafungin - Candidemia
Phase 4CompletedUniversidade Federal do Rio de Janeiro852012-11-012019-07-08
Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections
ClinSupV3 -soft gelatin capsule, ClinSupV3ER- Extended release tablet - Vaginal Infections
Phase 4CompletedDr Bharti Daswani732011-04-012012-10-02
An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis
Miconazole plus Hydrocortisone - Vulva; Candidiasis
Phase 4CompletedJanssen Pharmaceutica1152009-01-012013-03-25

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Candidiasis, Invasive (9)  ·  Candidemia (8)  ·  Candidiasis, Vulvovaginal (8)  ·  Candidiasis, Oral (4)  ·  Aspergillosis (3)  ·  Mycoses (3)  ·  Vaginosis, Bacterial (3)  ·  Invasive Fungal Infections (2)  ·  Torulopsis (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Asthma (1)  ·  Critical Illness (1)  ·  Cryptococcosis (1)

Broader conditions

Bacterial Infections and Mycoses (35)  ·  Infections (35)  ·  Mycoses (32)  ·  Genital Diseases (12)  ·  Invasive Fungal Infections (12)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Urogenital Diseases (12)  ·  Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Genital Diseases, Female (10)  ·  Pathologic Processes (10)  ·  Vaginal Diseases (10)  ·  Inflammation (9)  ·  Systemic Inflammatory Response Syndrome (9)

Interventions

Fluconazole (9)  ·  Micafungin (7)  ·  Anidulafungin (4)  ·  Clotrimazole (4)  ·  Voriconazole (4)  ·  Caspofungin (3)  ·  Miconazole (3)  ·  Clindamycin (2)  ·  liposomal amphotericin B (2)  ·  Anti-Bacterial Agents (1)  ·  Antifungal Agents (1)  ·  Blood Specimen Collection (1)  ·  Ciclopirox (1)  ·  Fluticasone (1)  ·  Hydrocortisone (1)

Sponsors

Pfizer (4)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Peking University Shenzhen Hospital (3)  ·  Astellas Pharma China, Inc. (2)  ·  Allergy & Asthma Medical Group & Research Center (1)  ·  Dr Bharti Daswani (1)  ·  Exeltis Turkey (1)  ·  Fadoi Foundation, Italy (1)  ·  Ferrer Internacional S.A. (1)  ·  Gary E. Stein, Pharm.D. (1)  ·  Gilead Sciences (1)  ·  Instituto Palacios (1)  ·  Janssen Pharmaceutica (1)  ·  Kyoto University (1)  ·  Laboratorios Ordesa (1)

Countries

United States (9)  ·  China (5)  ·  Italy (3)  ·  Brazil (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Chile (1)  ·  Colombia (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)

Top investigators

Shangrong Fan, M.D. (3)  ·  Bharti R Daswani, MD, PhD (1)  ·  Eli O Meltzer, MD (1)  ·  Filomena Puntillo, Professor (1)  ·  Francesco Bruno, Professor (1)  ·  Gary E Stein, Pharm.D. (1)  ·  Jose C Moreno, Prof, PhD (1)  ·  Juan A Tena, Dr. (1)  ·  Kurt T Barnhart, MD, MSCE (1)  ·  Luigi Picaro (1)  ·  Luis Ostrosky-Zeichner, MD (1)  ·  Manopchai Thamkhantho, Prof MD (1)

Results publications

PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293, PMID 19144094, PMID 22490643, PMID 23710653, PMID 24550378, PMID 24559321, PMID 25877666, PMID 27073145, PMID 27287231, PMID 32940765, PMID 41219680

NIH funding

2008 (1)